Bridgeway Capital Management’s CervoMed CRVO Stock Holding History

Bridgeway Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,043	Closed	-$55K	–	1380
2023 Q2	$55K	Hold	11,043	–	–	﹤0.01%	1331
2023 Q1	$68.9K	Hold	11,043	–	–	﹤0.01%	1285
2022 Q4	$84.5K	Hold	11,043	–	–	﹤0.01%	1240
2022 Q3	$89K	Hold	11,043	–	–	﹤0.01%	1293
2022 Q2	$109K	Buy	+11,043	New	+$137K	﹤0.01%	1209
2019 Q2	–	Sell	-281	Closed	-$78K	–	1335
2019 Q1	$78K	Buy	+281	New	+$67.4K	﹤0.01%	1297

Other funds holding CRVO

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bridgeway Capital Management's CRVO Position: Q3 2023 in Review

Bridgeway Capital Management sold out of CervoMed (CRVO) in Q3 2023, closing a stake of 11,043 shares — an estimated $55K sold.

Bridgeway Capital Management first reported a position in CRVO in Q1 2019 and held it in 6 quarters. The position peaked at $109K in Q2 2022. 12 funds tracked by Wall St. Rank hold CRVO as of Q3 2023.

Bridgeway Capital Management reported no remaining CervoMed position as of Q3 2023 after selling out during the quarter.
Bridgeway Capital Management sold 11,043 CervoMed shares in Q3 2023, an estimated $55K.
Bridgeway Capital Management first reported a position in CervoMed in Q1 2019 and held it in 6 quarters.
Bridgeway Capital Management's CervoMed position peaked at $109K in Q2 2022.
12 funds tracked by Wall St. Rank held CervoMed as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.